ANTI-VIRAL COMPOUNDS

To provide: compounds effective in inhibiting replication of Hepatitis C virus ("HCV"); pharmaceutical compositions comprising such compounds, processes of making the compounds, and methods of using such compounds to treat HCV infection.SOLUTION: The invention provides compounds having the...

Full description

Saved in:
Bibliographic Details
Main Authors PATEL, SACHEL V, KEDDY, RYAN G, HUTCHINS, CHARLES W, CARROLL, WILLIAM A, WAGAW, SEBEL H, LIU, DACHUN, DONNER, PAMELA L, RANDOLPH, JOHN T, ROCKWAY, TODD W, GAO, YI, KATI, WARREN M, TUFANO, MICHAEL D, HUTCHINSON, DOUGLAS K, KRUEGER, ALLAN C, FLENTGE, CHARLES A, BETEBENNER, DAVID A, JINKERSON, TAMMIE K, SARRIS, KATHY, MARING, CLARENCE J, BELIZZI, MARY E, LI, WENKE, DEGOEY, DAVID A, WAGNER, ROLF, CALIFANO, JEAN C, CASPI, DANIEL D, WOLLER, KEVIN R, NELSON, LISSA T, PRATT, JOHN K, MOTTER, CHRISTOPHER E, MATULENKO, MARK A
Format Patent
LanguageEnglish
French
Published 19.04.2012
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:To provide: compounds effective in inhibiting replication of Hepatitis C virus ("HCV"); pharmaceutical compositions comprising such compounds, processes of making the compounds, and methods of using such compounds to treat HCV infection.SOLUTION: The invention provides compounds having the formula I in the figure, or pharmaceutically acceptable salts of the compounds.SELECTED DRAWING: None
Bibliography:Application Number: CA20112938547